126 related articles for article (PubMed ID: 8745350)
1. Docetaxel: an interesting new drug for the treatment of head and neck cancers and soft tissue sarcomas.
Verweij J
Anticancer Drugs; 1995 Jul; 6 Suppl 4():19-24. PubMed ID: 8745350
[TBL] [Abstract][Full Text] [Related]
2. Phase II studies of docetaxel in the treatment of various solid tumours. EORTC Early Clinical Trials Group and the EORTC Soft Tissue and Bone Sarcoma Group.
Verweij J; Catimel G; Sulkes A; Sternberg C; Wolff I; Aamdal S; van Hoesel Q
Eur J Cancer; 1995; 31A Suppl 4():S21-4. PubMed ID: 7577101
[TBL] [Abstract][Full Text] [Related]
3. Phase II study with docetaxel (Taxotere) in advanced soft tissue sarcomas of the adult. EORTC Soft Tissue and Bone Sarcoma Group.
van Hoesel QG; Verweij J; Catimel G; Clavel M; Kerbrat P; van Oosterom AT; Kerger J; Tursz T; van Glabbeke M; van Pottelsberghe C
Ann Oncol; 1994 Jul; 5(6):539-42. PubMed ID: 7918126
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of docetaxel in advanced soft tissue sarcomas.
Edmonson JH; Ebbert LP; Nascimento AG; Jung SH; McGaw H; Gerstner JB
Am J Clin Oncol; 1996 Dec; 19(6):574-6. PubMed ID: 8931674
[TBL] [Abstract][Full Text] [Related]
5. Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.
Catimel G; Verweij J; Mattijssen V; Hanauske A; Piccart M; Wanders J; Franklin H; Le Bail N; Clavel M; Kaye SB
Ann Oncol; 1994 Jul; 5(6):533-7. PubMed ID: 7918125
[TBL] [Abstract][Full Text] [Related]
6. A Phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck.
Tishler RB; Norris CM; Colevas AD; Lamb CC; Karp D; Busse PM; Nixon A; Frankenthaler R; Lake-Willcutt B; Costello R; Case M; Posner MR
Cancer; 2002 Oct; 95(7):1472-81. PubMed ID: 12237916
[TBL] [Abstract][Full Text] [Related]
7. Randomized phase II study of docetaxel versus doxorubicin in first- and second-line chemotherapy for locally advanced or metastatic soft tissue sarcomas in adults: a study of the european organization for research and treatment of cancer soft tissue and bone sarcoma group.
Verweij J; Lee SM; Ruka W; Buesa J; Coleman R; van Hoessel R; Seynaeve C; di Paola ED; van Glabbeke M; Tonelli D; Judson IR
J Clin Oncol; 2000 May; 18(10):2081-6. PubMed ID: 10811673
[TBL] [Abstract][Full Text] [Related]
8. Docetaxel: an active drug for squamous cell carcinoma of the head and neck.
Dreyfuss AI; Clark JR; Norris CM; Rossi RM; Lucarini JW; Busse PM; Poulin MD; Thornhill L; Costello R; Posner MR
J Clin Oncol; 1996 May; 14(5):1672-8. PubMed ID: 8622087
[TBL] [Abstract][Full Text] [Related]
9. Advanced head and neck cancer and clinical experience of an effective new agent: docetaxel.
Schöffski P; Weihkopf T; Ganser A
Anticancer Res; 1998; 18(6B):4751-6. PubMed ID: 9891552
[TBL] [Abstract][Full Text] [Related]
10. Combination docetaxel/cyclophosphamide in patients with advanced solid tumors.
Valero V
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):34-6. PubMed ID: 9364540
[TBL] [Abstract][Full Text] [Related]
11. [Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent head and neck cancer].
Inuyama Y; Kataura A; Togawa K; Saijo S; Satake B; Takeoda S; Konno A; Ebihara S; Sasaki Y; Kida A; Kanzaki J; Ichikawa G; Kono N; Moriyama H; Kamata S; Miyake H; Sakai M; Horiuchi M; Kubota A; Tsukuda M; Matsuura H; Baba S; Saito H; Matsunaga T; Taguchi T
Gan To Kagaku Ryoho; 1999 Jan; 26(1):107-16. PubMed ID: 9987506
[TBL] [Abstract][Full Text] [Related]
12. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
[TBL] [Abstract][Full Text] [Related]
13. A multicentre phase II study of docetaxel 75 mg m-2 as first-line chemotherapy for patients with advanced breast cancer: report of the Clinical Screening Group of the EORTC. European Organization for Research and Treatment of Cancer.
Dieras V; Chevallier B; Kerbrat P; Krakowski I; Roche H; Misset JL; Lentz MA; Azli N; Murawsky M; Riva A; Pouillart P; Fumoleau P
Br J Cancer; 1996 Aug; 74(4):650-6. PubMed ID: 8761385
[TBL] [Abstract][Full Text] [Related]
14. Docetaxel: a new defence in the management of breast cancer.
Piccart M
Anticancer Drugs; 1995 Jul; 6 Suppl 4():7-11. PubMed ID: 8745348
[TBL] [Abstract][Full Text] [Related]
15. Docetaxel as rescue medication in anthracycline- and ifosfamide-resistant locally advanced or metastatic soft tissue sarcoma: results of a phase II trial.
Köstler WJ; Brodowicz T; Attems Y; Hejna M; Tomek S; Amann G; Fiebiger WC; Wiltschke CH; Krainer M; Zielinski CC
Ann Oncol; 2001 Sep; 12(9):1281-8. PubMed ID: 11697841
[TBL] [Abstract][Full Text] [Related]
16. Docetaxel delivers new management opportunities for gastrointestinal carcinomas.
Rougier P
Anticancer Drugs; 1995 Jul; 6 Suppl 4():25-9. PubMed ID: 8745351
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of single-agent docetaxel chemotherapy for non-small cell lung cancer.
Perng RP; Shih JF; Chen YM; Chou KC; Lee YC; Tsai CM
Jpn J Clin Oncol; 2000 Oct; 30(10):429-34. PubMed ID: 11185888
[TBL] [Abstract][Full Text] [Related]
18. Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF): a phase II trial.
Mavroudis D; Kourousis C; Androulakis N; Kalbakis K; Agelaki S; Kakolyris S; Souglakos J; Sarra E; Vardakis N; Hatzidaki D; Sarmonis G; Georgoulias V
Am J Clin Oncol; 2000 Aug; 23(4):341-4. PubMed ID: 10955859
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck.
Couteau C; Chouaki N; Leyvraz S; Oulid-Aissa D; Lebecq A; Domenge C; Groult V; Bordessoule S; Janot F; De Forni M; Armand JP
Br J Cancer; 1999 Oct; 81(3):457-62. PubMed ID: 10507770
[TBL] [Abstract][Full Text] [Related]
20. Docetaxel in squamous cell cancer of the head and neck.
Posner MR
Anticancer Drugs; 2001 Feb; 12 Suppl 1():S21-4. PubMed ID: 11340900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
